ArticleIntensive care medicine2022

Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.

Shodai Yoshihiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.